New hybrid catheterization table for Toshiba America Medical Systems' five-axis Infinix-i cardiovascular X-ray line

NewsGuard 100/100 Score

Toshiba America Medical Systems, Inc. has introduced the CAT-880B, a new hybrid catheterization table, for its five-axis InfinixTM-i cardiovascular X-ray line. Toshiba will feature the new hybrid table at this year’s Radiological Society of North America (RSNA) annual meeting, held in Chicago, Nov. 29 – Dec. 4 (Booth #5629, South Hall).

The new integrated hybrid catheterization table offers head-to-toe tilting and side-to-side cradling to meet the needs of both interventionalists and surgeons during hybrid intervention. Combining the new table with the unparalleled patient access and coverage achieved by Toshiba’s Infinix-i five-axis X-ray systems creates a best-in-class hybrid lab unmatched in the industry today.

Dr. John Cheatham, director, Cardiac Catheterization and Interventional Therapy, and Dr. Mark Galantowicz, chief, Cardiothoracic Surgery, both of The Heart Center of Nationwide Children's Hospital, are recognized for pioneering the hybrid approach to treat congenital heart conditions. Both physicians worked with Toshiba engineers to design the new table and evaluated the prototype to ensure it met their needs in a real-life hybrid setting. Today, Nationwide Children’s is the first site with this hybrid catheterization table in use at its hybrid cath lab.

“Using this new hybrid catheterization table in conjunction with Toshiba’s bi-plane five-axis cath lab is the final piece in creating a premium hybrid suite,” explains Dr. Cheatham. “The table is uniquely designed to meet the individual needs of both interventionalists and surgeons. It allows them to perform the same functions used in their respective home environments – the operating room and the cath lab – together in a single hybrid suite without any sacrifice in patient access, ergonomics or efficiency.”

When working on patients in a hybrid setting, it is critical the imaging system provides outstanding image quality, as well as the flexibility to reach ancillary equipment and the patient quickly and easily. The new hybrid catheterization table features a 550-pound table weight limit, making this table ideal for a range of patients, from pediatric to bariatric. It also allows for angulations of up to 16 degrees in all four directions and offers the lowest table-top height of any catheterization table in the industry. The 75-cm table height is particularly important for open surgical procedures, as it provides ultimate patient access and physician comfort, regardless of the procedure being performed. With the new table, Toshiba’s Infinix-i five-axis X-ray systems are designed to accommodate endovascular catheter based techniques, open surgical settings or a combined hybrid approach, for procedures including hypoplastic left heart syndrome and intraoperative stent therapy.

“Patient access is critical for endovascular, open surgical or hybrid cath lab procedures because it allows physicians to complete the exam more easily and more comfortably,” said Robert Micer, director, X-ray Vascular Business Unit, Toshiba. “The CAT-880B hybrid catheterization table is designed to create the ideal hybrid cath lab when combined with our Infinix-i five-axis X-ray systems.”

The table is currently available on all five-axis Infinix-i systems and will be available for other Infinix-i configurations in the near future.

SOURCE Toshiba America Medical Systems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Integrating social determinants of health to enhance heart failure risk prediction